Skip to main content
NIH funding notice RFA-DA-21-024

PrEP for HIV Prevention among Substance Using Populations (R01 - Clinical Trial Optional)

Closed on November 12, 2020.

Posted
June 29, 2020
Close date
November 12, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,487,036 in first-year total cost, median $743,518.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 TXT-V (09)]2

Most frequent institutions

  1. COLUMBIA UNIVERSITY HEALTH SCIENCES1
  2. DREXEL UNIVERSITY1
Competing awards under RFA-DA-21-024 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Cannabis use, PrEP and HIV transmission risk Among Black MSM in Chicago1R01DA054553-01DUNCAN, DUSTIN TKNOX, JUSTINCOLUMBIA UNIVERSITY HEALTH SCIENCES, NY$760,201ZDA1
2021Efficacy of a Trauma Intervention for Affect Regulation, Adherence, and Substance Use to Optimize PrEP for Women Who Inject Drugs1R01DA054543-01ROTH, ALEXIS MARIEDREXEL UNIVERSITY, PA$726,835ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.